Silence Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Silence Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 45% to $25,375,000. Profit margin reached -171%. Total operating expenses were $64,661,000.
Profit Margin
| 2014 | 15K | -11.08M | -73920% |
|---|---|---|---|
| 2015 | 0 | -6.64M | |
| 2016 | 770K | -8.44M | -1096.1% |
| 2017 | 16K | -1.61M | -10112.5% |
| 2018 | 0 | -18.41M | |
| 2019 | 244K | -19.58M | -8025.41% |
| 2020 | 5.47M | -32.54M | -594.03% |
| 2021 | 12.41M | -39.41M | -317.44% |
| 2022 | 17.50M | -40.48M | -231.35% |
| 2023 | 25.37M | -43.26M | -170.51% |
SLN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 25.37M | 17.50M | 12.41M | 5.47M | 244K | 0 | 16K | 770K | 0 | 15K |
Cost of revenue | 10.31M | 10.88M | 7.45M | 3.76M | 0 | 0 | 7.94M | 0 | 7.11M | 8.88M |
Gross profit | 15.05M | 6.62M | 4.95M | 1.71M | 244K | 0 | -7.92M | 770K | -7.11M | -8.86M |
Operating exp. | ||||||||||
Research and development | 44.02M | 35.60M | 30.76M | 20.20M | 13.33M | 9.74M | 7.94M | 8.71M | 7.11M | 8.88M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 64.66M | 55.21M | 50.77M | 37.56M | 22.97M | 20.57M | 14.40M | 12.67M | 9.76M | 12.14M |
Operating income | -49.60M | -48.59M | -45.81M | -35.84M | -22.73M | -20.57M | -14.39M | -11.90M | -9.76M | -12.12M |
Other income (expenses), net | -706K | 1.22M | -42K | -194K | -136K | 6K | 10.61M | 1.54M | 340K | 147K |
Income before tax | -50.31M | -47.36M | -45.85M | -36.04M | -22.87M | -20.52M | -3.77M | -10.36M | -9.42M | -11.98M |
Income tax expense | -7.04M | -6.87M | -6.44M | -3.49M | -3.28M | -2.11M | -2.15M | -1.92M | -2.78M | -892K |
Net income | -43.26M | -40.48M | -39.41M | -32.54M | -19.58M | -18.41M | -1.61M | -8.44M | -6.64M | -11.08M |
Earnings per share | ||||||||||
Basic EPS | -1.17 | -1.26 | -1.33 | -1.19 | -0.78 | -0.79 | -0.06 | -0.36 | -0.31 | -0.66 |
Diluted EPS | -1.17 | -1.26 | -1.33 | -1.19 | -0.78 | -0.79 | -0.06 | -0.36 | -0.31 | -0.66 |
| Data source | Data source | Data source | Data source |